Home
RXST
RXST News

Latest RxSight Inc. (RXST) News on November 4, 2025

RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025

GlobeNewswire

12 days ago

RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025

RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting

GlobeNewswire

18 days ago

RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting

Here's Why We're Not At All Concerned With RxSight's (NASDAQ:RXST) Cash Burn Situation

Simply Wall St.

4 months ago

Here's Why We're Not At All Concerned With RxSight's (NASDAQ:RXST) Cash Burn Situation

FMS or RXST: Which Is the Better Value Stock Right Now?

Zacks

5 months ago

FMS or RXST: Which Is the Better Value Stock Right Now?

Down Over 30%: Wells Fargo Says Now Is the Time to Load Up on These 2 Beaten-Down Stocks

TipRanks

5 months ago

Down Over 30%: Wells Fargo Says Now Is the Time to Load Up on These 2 Beaten-Down Stocks

Do Options Traders Know Something About RxSight Stock We Don't?

Zacks

5 months ago

Do Options Traders Know Something About RxSight Stock We Don't?

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum

GlobeNewswire

5 months ago

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum

Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued

Insider Monkey

5 months ago

Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued

MT Newswires

5 months ago

RxSight Shares Rise After Upgrade From Wells Fargo

MT Newswires

6 months ago

Wells Fargo Upgrades RxSight to Overweight From Equalweight, Lifts Price Target to $25 From $17

MT Newswires

6 months ago

Medical Technology Firms Face Price Target Revisions From Morgan Stanley

MT Newswires

6 months ago

Morgan Stanley Adjusts Price Target on RxSight to $20 From $42, Maintains Overweight Rating

RxSight, Inc. (NASDAQ:RXST) Just Reported Earnings, And Analysts Cut Their Target Price

Simply Wall St.

6 months ago

RxSight, Inc. (NASDAQ:RXST) Just Reported Earnings, And Analysts Cut Their Target Price

GuruFocus.com

6 months ago

RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances Amid ...

RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

Zacks

6 months ago

RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

RxSight, Inc. Reports First Quarter 2025 Financial Results

GlobeNewswire

6 months ago

RxSight, Inc. Reports First Quarter 2025 Financial Results

CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

6 months ago

CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

RxSight, Inc. to Present at the Bank of America Healthcare Conference

GlobeNewswire

6 months ago

RxSight, Inc. to Present at the Bank of America Healthcare Conference

RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

6 months ago

RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

What Does RxSight, Inc.'s (NASDAQ:RXST) Share Price Indicate?

Simply Wall St.

6 months ago

What Does RxSight, Inc.'s (NASDAQ:RXST) Share Price Indicate?

RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025

GlobeNewswire

6 months ago

RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025

MT Newswires

7 months ago

Piper Sandler Initiates RxSight at Neutral With $18 Price Target

MT Newswires

7 months ago

Needham Cuts Price Target on RxSight to $22 From $43, Keeps Buy Rating

MT Newswires

7 months ago

UBS Downgrades RxSight to Neutral From Buy, Cuts Price Target to $16 From $45

Investing.com

7 months ago

JP Morgan downgrades RxSight on market, competitive pressures

Block upgraded, Nvidia downgraded: Wall Street’s top analyst calls

TipRanks

7 months ago

Block upgraded, Nvidia downgraded: Wall Street’s top analyst calls

Is RxSight, Inc. (NASDAQ:RXST) Trading At A 39% Discount?

Simply Wall St.

7 months ago

Is RxSight, Inc. (NASDAQ:RXST) Trading At A 39% Discount?

MT Newswires

7 months ago

JPMorgan Downgrades RxSight to Underweight From Overweight, Adjusts Price Target to $17 From $40

GuruFocus.com

7 months ago

RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Strong Year-Over-Year Growth Amid Revised ...

Thomson Reuters StreetEvents

7 months ago

Preliminary Q1 2025 Rxsight Inc Earnings Call

RxSight Plunges 44% After Slashing 2025 Guidance; Bank of America Downgrades Stock

GuruFocus.com

7 months ago

RxSight Plunges 44% After Slashing 2025 Guidance; Bank of America Downgrades Stock

MT Newswires

7 months ago

RxSight Q1 Revenue Miss, Guidance Cut Raise Growth Concerns, BofA Says

MT Newswires

7 months ago

Sector Update: Health Care Stocks Lean Lower Premarket Thursday

MT Newswires

7 months ago

Sector Update: Health Care

RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges

Benzinga

7 months ago

RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges

MT Newswires

7 months ago

RxSight Preliminary Q1 Revenue Increases; Lowers 2025 Revenue Guidance

RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance

GlobeNewswire

7 months ago

RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

7 months ago

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

MT Newswires

8 months ago

Top Premarket Gainers

RxSight, Inc. (NASDAQ:RXST) Just Reported, And Analysts Assigned A US$44.80 Price Target

Simply Wall St.

8 months ago

RxSight, Inc. (NASDAQ:RXST) Just Reported, And Analysts Assigned A US$44.80 Price Target

RxSight Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

8 months ago

RxSight Full Year 2024 Earnings: EPS Beats Expectations

GuruFocus.com

8 months ago

RxSight Inc (RXST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

RxSight, Inc. (RXST) Misses Q4 Earnings Estimates

Zacks

8 months ago

RxSight, Inc. (RXST) Misses Q4 Earnings Estimates

RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance

GlobeNewswire

8 months ago

RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance

GuruFocus.com

8 months ago

What To Expect From RxSight Inc (RXST) Q4 2024 Earnings

RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025

GlobeNewswire

9 months ago

RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025

Insider Stock Buying Reaches US$1.83m On RxSight

Simply Wall St.

9 months ago

Insider Stock Buying Reaches US$1.83m On RxSight

RxSight price target lowered to $43 from $66 at Needham

TipRanks

10 months ago

RxSight price target lowered to $43 from $66 at Needham

MT Newswires

10 months ago

RxSight Reports Preliminary Q4 Revenue, Issues 2025 Outlook

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

GlobeNewswire

10 months ago

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

GlobeNewswire

10 months ago

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

MT Newswires

10 months ago

RxSight Shares Fall After Stifel Downgrade

Do You Believe in the Long-Term Growth Potential of RxSight (RXST)?

Insider Monkey

10 months ago

Do You Believe in the Long-Term Growth Potential of RxSight (RXST)?

MT Newswires

10 months ago

Stifel Downgrades RxSight to Hold From Buy, Adjusts Price Target to $40 From $65

Positive week for RxSight, Inc. (NASDAQ:RXST) institutional investors who lost 1.6% over the past year

Simply Wall St.

10 months ago

Positive week for RxSight, Inc. (NASDAQ:RXST) institutional investors who lost 1.6% over the past year

MT Newswires

a year ago

Wells Fargo Downgrades RxSight to Equal Weight From Overweight, $56 Price Target

MT Newswires

a year ago

UBS Initiates RxSight at Buy With $52 Price Target

RxSight (RXST) Upgraded to Buy: Here's What You Should Know

Zacks

a year ago

RxSight (RXST) Upgraded to Buy: Here's What You Should Know

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 11/15/2024

MT Newswires

a year ago

RxSight Insider Bought Shares Worth $1,014,570, According to a Recent SEC Filing

RxSight, Inc. (NASDAQ:RXST) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Simply Wall St.

a year ago

RxSight, Inc. (NASDAQ:RXST) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

GuruFocus.com

a year ago

RxSight Inc (RXST) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Market ...

RxSight, Inc. (RXST) Reports Break-Even Earnings for Q3

Zacks

a year ago

RxSight, Inc. (RXST) Reports Break-Even Earnings for Q3

RxSight, Inc. Reports Third Quarter 2024 Financial Results

GlobeNewswire

a year ago

RxSight, Inc. Reports Third Quarter 2024 Financial Results

What To Expect From RxSight Inc (RXST) Q3 2024 Earnings

GuruFocus.com

a year ago

What To Expect From RxSight Inc (RXST) Q3 2024 Earnings

Is It Too Late To Consider Buying RxSight, Inc. (NASDAQ:RXST)?

Simply Wall St.

a year ago

Is It Too Late To Consider Buying RxSight, Inc. (NASDAQ:RXST)?

MT Newswires

a year ago

Jefferies Initiates RxSight at Buy With $72 Price Target

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

GlobeNewswire

a year ago

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

MT Newswires

a year ago

Rxsight Insider Sold Shares Worth $309,850, According to a Recent SEC Filing

RxSight, Inc. (RXST): A Visionary Small-Cap Stock Pick by Hedge Funds

Insider Monkey

a year ago

RxSight, Inc. (RXST): A Visionary Small-Cap Stock Pick by Hedge Funds

MT Newswires

a year ago

Rxsight Insider Sold Shares Worth $462,458, According to a Recent SEC Filing

RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now

Insider Monkey

a year ago

RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now

MT Newswires

a year ago

RxSight Insider Sold Shares Worth $328,164, According to a Recent SEC Filing

Here's Why We're Not At All Concerned With RxSight's (NASDAQ:RXST) Cash Burn Situation

Simply Wall St.

a year ago

Here's Why We're Not At All Concerned With RxSight's (NASDAQ:RXST) Cash Burn Situation

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

GlobeNewswire

a year ago

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

MT Newswires

a year ago

Needham Raises Price Target on RxSight to $66 From $54, Adds Stock to Conviction List, Keeps Buy Rating

RxSight Stock Sees Relative Strength Rating Rise To 91

Investor's Business Daily

a year ago

RxSight Stock Sees Relative Strength Rating Rise To 91

Does RxSight (RXST) Have the Potential to Rally 27.64% as Wall Street Analysts Expect?

Zacks

a year ago

Does RxSight (RXST) Have the Potential to Rally 27.64% as Wall Street Analysts Expect?

US$63.00: That's What Analysts Think RxSight, Inc. (NASDAQ:RXST) Is Worth After Its Latest Results

Simply Wall St.

a year ago

US$63.00: That's What Analysts Think RxSight, Inc. (NASDAQ:RXST) Is Worth After Its Latest Results

Thomson Reuters StreetEvents

a year ago

Q2 2024 Rxsight Inc Earnings Call

MT Newswires

a year ago

Oppenheimer Adjusts RxSight Price Target to $65 From $72, Maintains Outperform Rating

MT Newswires

a year ago

Needham Cuts Price Target on RxSight to $54 From $75, Keeps Buy Rating

MT Newswires

a year ago

RxSight Reports Breakeven Q2 Adjusted Earnings as Revenue Increases; Raises 2024 Revenue Guidance

RxSight, Inc. (RXST) Reports Break-Even Earnings for Q2

Zacks

a year ago

RxSight, Inc. (RXST) Reports Break-Even Earnings for Q2

RxSight, Inc. Reports Second Quarter 2024 Financial Results

GlobeNewswire

a year ago

RxSight, Inc. Reports Second Quarter 2024 Financial Results

Down -26.04% in 4 Weeks, Here's Why RxSight (RXST) Looks Ripe for a Turnaround

Zacks

a year ago

Down -26.04% in 4 Weeks, Here's Why RxSight (RXST) Looks Ripe for a Turnaround

Exploring Undervalued Small Caps With Insider Action In The United States July 2024

Simply Wall St.

a year ago

Exploring Undervalued Small Caps With Insider Action In The United States July 2024

RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024

GlobeNewswire

a year ago

RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024

RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

a year ago

RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Dow Jones Jumps 429 Points On Fed Chief's Comments; Gold Miners, Chips Rally (Live Coverage)

Investor's Business Daily

a year ago

Dow Jones Jumps 429 Points On Fed Chief's Comments; Gold Miners, Chips Rally (Live Coverage)

MT Newswires

a year ago

Stifel Adjusts Price Target on RxSight to $70 From $75, Maintains Buy Rating

Institutional investors control 71% of RxSight, Inc. (NASDAQ:RXST) and were rewarded last week after stock increased 6.0%

Simply Wall St.

a year ago

Institutional investors control 71% of RxSight, Inc. (NASDAQ:RXST) and were rewarded last week after stock increased 6.0%

MT Newswires

a year ago

RxSight Insider Sold Shares Worth $906,288, According to a Recent SEC Filing

Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST)

GuruFocus.com

a year ago

Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST)

Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock

Investor's Business Daily

a year ago

Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock

These 5 Companies Lost Money. Here's Why They're Still On The IBD 50.

Investor's Business Daily

a year ago

These 5 Companies Lost Money. Here's Why They're Still On The IBD 50.

RxSight, Inc. To Participate in the Truist Securities Medtech Conference

GlobeNewswire

a year ago

RxSight, Inc. To Participate in the Truist Securities Medtech Conference

Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board

GlobeNewswire

a year ago

Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board

What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now?

Zacks

a year ago

What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now?

Buy 5 Medical Instruments Stocks to Enhance Your Portfolio

Zacks

a year ago

Buy 5 Medical Instruments Stocks to Enhance Your Portfolio

Share on Social Networks: